CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells (CD30.CAR EBVSTs) Provide a Safe and Effective Off-the-Shelf Therapy for Patients with CD30-Positive Lymphoma
Year: 2022
Type: article
Study design: Clinical Trial
Source: Blood
Authors: David H. Quach, Carlos A. Ramos, Premal D. Lulla, Sandhya Sharma, Haran R. Ganesh, Nazila Nouraee, Yolanda D. Briones, Yezan F. Hadidi, Luis Becerra-Dominguez, Sachin G. Thakkar, Birju Mehta, Silvana Perconti, Emily M. Hsieh, Huimin Zhang, Bambi J. Grilley, Malcolm K. Brenner, Helen E. Heslop, Rayne H. Rouce, Natalia Lapteva, Cliona M. Rooney
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310107108